<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Siegfried</forename><surname>Breitling</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department">Institute for Chemistry and Biochemistry</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhang</forename><surname>Hui</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Diana</forename><surname>Zabini</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Yijie</forename><surname>Hu</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Julia</forename><surname>Hoffmann</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Neil</forename><forename type="middle">M</forename><surname>Goldenberg</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Arata</forename><surname>Tabuchi</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Roland</forename><surname>Buelow</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">Open Monoclonal Technology</orgName>
								<address>
									<settlement>Incorporated, Palo Alto</settlement>
									<region>California</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><forename type="middle">Dos</forename><surname>Santos</surname></persName>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Wolfgang</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
							<email>wolfgang.kuebler@charite.de</email>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">Keenan Research Centre for Biomedical Science</orgName>
								<orgName type="institution" key="instit2">St. Michael&apos;s Hospital</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Institute of Physiology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Departments of Surgery and Physiology</orgName>
								<orgName type="institution">University of Toronto</orgName>
								<address>
									<settlement>Toronto</settlement>
									<region>Ontario</region>
									<country key="CA">Canada</country>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="institution">German Heart Institute Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Inst. of Physiology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Charitéplatz 1</addrLine>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The mast cell-B cell axis in lung vascular remodeling and pulmonary hypertension</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">E327F2441B507C4140EB4F4F05F34F6A</idno>
					<idno type="DOI">10.1152/ajplung.00311.2016.-</idno>
					<note type="submission">Submitted 26 July 2016; accepted in final form 15 February 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:39+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Over past years, a critical role for the immune system and, in particular, for mast cells in the pathogenesis of pulmonary hypertension (PH) has emerged.</s><s>However, the way in which mast cells promote PH is still poorly understood.</s><s>Here, we investigated the mechanisms by which mast cells may contribute to PH, specifically focusing on the interaction between the innate and adaptive immune response and the role of B cells and autoimmunity.</s><s>Experiments were performed in Sprague-Dawley rats and B cell-deficient JH-KO rats in the monocrotaline, Sugen/hypoxia, and the aortic banding model of PH.</s><s>Hemodynamics, cell infiltration, IL-6 expression, and vascular remodeling were analyzed.</s><s>Gene array analyses revealed constituents of immunoglobulins as most prominently regulated mast cell-dependent genes in the lung in experimental PH.</s><s>IL-6 was shown to link mast cells to B cells, as 1) IL-6 was upregulated and colocalized with mast cells and was reduced by mast-cell stabilizers and 2) IL-6 or mast cell blockade reduced B cells in lungs of monocrotaline-treated rats.</s><s>A functional role for B cells in PH was demonstrated in that either blocking B cells by an anti-CD20 antibody or B-cell deficiency in JH-KO rats attenuated right ventricular systolic pressure and vascular remodeling in experimental PH.</s><s>We here identify a mast cell-B cell axis driven by IL-6 as a critical immune pathway in the pathophysiology of PH.</s><s>Our results provide novel insights into the role of the immune system in PH, which may be therapeutically exploited by targeted immunotherapy.</s><s>pulmonary hypertension; inflammation; B cells; mast cells CLINICALLY, PULMONARY HYPERTENSION (PH) is defined by a mean pulmonary arterial pressure Ͼ25 mmHg at rest.</s><s>At the pathological level, PH is characterized by a progressive increase in lung vascular resistance and severe lung vascular remodeling ultimately leading to right ventricular failure (36).</s><s>Without treatment, the 5-yr survival rate is abysmal at 34% (23), and even with treatment the 5-yr survival rate remains ~60% (10), underlining the unmet clinical need for better mechanistic insights and novel therapies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Over the past decade, a potential role for the immune system in PH has emerged in that various immune cells infiltrate around plexiform lesions and remodeled pulmonary vessels and are associated with increased cytokine levels in patients with idiopathic pulmonary arterial hypertension (PAH) and secondary PH forms and in animal models of the disease <ref type="bibr" target="#b20">(19,</ref><ref type="bibr" target="#b39">38,</ref><ref type="bibr" target="#b47">45)</ref>.</s><s>Specifically, work published by others and us has revealed an important functional role for mast cells in PH in that both pharmacological inhibition and genetic depletion of mast cells significantly improved hemodynamics and vascular remodeling in experimental models of PH <ref type="bibr" target="#b9">(8,</ref><ref type="bibr" target="#b18">17)</ref>.</s></p><p><s>The notion of a critical involvement of the immune system has lately been expanded from the innate to the adaptive immune response, involving T and B cells.</s><s>Recently, the presence of tertiary lymphoid tissue (tLT) in the form of bronchus-associated lymphoid tissue has been described in both animal models of PH and human tissue from PAH patients <ref type="bibr" target="#b32">(31)</ref>.</s><s>Notably, tLTs are commonly associated with autoimmune diseases <ref type="bibr" target="#b34">(33)</ref>.</s><s>In line with this view, autoantibodies against various targets have been detected in idiopathic pulmonary arterial hypertension (iPAH) patients, including antiendothelin receptor type A, antiangiotensin receptor type-1 (4), antinuclear antibodies <ref type="bibr" target="#b51">(49)</ref>, anti-endothelial-cell antibodies <ref type="bibr" target="#b0">(1)</ref>, and anti-fibrillin-1 antibodies <ref type="bibr" target="#b28">(27)</ref> in 15.6, 21.0, 42.5, 62.1, and 93.0% of iPAH patients, respectively, suggesting autoimmunity as an important factor in PAH and potentially also in other forms of PH.</s><s>However, what triggers the formation of tLTs and the development of autoimmunity in PH remains so far unclear.</s><s>Mast cells have been reported to possess the potential to stimulate the activation and proliferation of B cells <ref type="bibr" target="#b26">(25,</ref><ref type="bibr" target="#b46">44)</ref>.</s><s>In this context, interleukin-6 (IL-6) presents an attractive candidate to link innate and adaptive immune responses in PH, as IL-6 release from mast cells can trigger B-cell proliferation and differentiation <ref type="bibr" target="#b26">(25)</ref> and because of the well-documented presence and pathogenic role of IL-6 in PH patients and animal models, respectively <ref type="bibr" target="#b39">(38)</ref>.</s></p><p><s>In the present study, we therefore probed for a potential link between innate and adaptive immunity in experimental PH.</s><s>We hypothesized that mast cells 1) exert their previously demonstrated pathogenic effect in PH via the recruitment of B cells, the formation of tLTs, and the development of autoimmunity, which then promotes vascular remodeling and PH, and 2) mediate the formation of tLTs via release of IL-6.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>Animal models.</s><s>For the monocrotaline (MCT) and Sugen/hypoxia model of PAH, male Sprague-Dawley (Charles River Laboratories, Saint-Constant, Quebec, Canada) and B cell-deficient JH-KO rats [generously provided by Open Monoclonal Technology (OMT), Palo Alto, CA] of 200 -220 g were used, and for the aortic banding model of pulmonary hypertension secondary to left heart disease <ref type="bibr" target="#b6">(5)</ref>, male Sprague-Dawley rats of 90 -100 g were used.</s><s>All animals received care in accordance with the National Institutes of Health's Guide for the Care and Use of Laboratory Animals (NIH Publication No. 80 <ref type="bibr">-23, Revised 1978</ref>).</s><s>The study was approved by the Animal Care Committee of St. Michael's Hospital.</s><s>In the MCT model, PH was induced by a single, intraperitoneal injection of 60 mg/kg MCT (Sigma-Aldrich, St. Louis, MO), and PH and lung vascular remodeling were assessed after 3 wk.</s><s>In the Sugen/hypoxia model, rats were injected with a single dose of 20 mg/kg SU 5416 (Tocris Bioscience, Ellisville, MO) at the inception of the study and subsequently housed under hypoxic conditions (10% O2) for 3 wk followed by another 2 wk under normoxic conditions <ref type="bibr" target="#b44">(42)</ref>.</s><s>In the aortic banding model, congestive heart failure was induced by surgical implantation of a titanium clip with an open diameter of 0.8 mm around the ascending aorta <ref type="bibr" target="#b15">(14,</ref><ref type="bibr" target="#b52">50)</ref>.</s><s>Sham-operated rats served as controls.</s><s>PH and lung vascular remodeling were either assessed 9 wk after aortic banding or sham operation, respectively, for end-point measurements or at days 1, <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b6">5,</ref><ref type="bibr" target="#b9">8,</ref><ref type="bibr" target="#b16">15,</ref><ref type="bibr" target="#b23">22,</ref><ref type="bibr" target="#b37">36,</ref><ref type="bibr" target="#b52">50</ref>, or 64 after aortic banding for time profile analyses.</s></p><p><s>Treatment regimens.</s><s>B cells were depleted by weekly intraperitoneal administration of 5 mg/kg murine monoclonal anti-CD20 antibody (generously provided by Genentech, San Francisco, CA).</s><s>Injections started 2 wk before the induction of PAH by MCT treatment or Sugen/hypoxia, respectively <ref type="bibr" target="#b41">(40)</ref>.</s><s>Control animals received an isotype-matched control antibody via the identical administration scheme.</s><s>IL-6 was depleted by daily intraperitoneal administration of 1 g/kg anti-IL-6 neutralizing antibody (R&amp;D Systems, Minneapolis, MN) starting 7 days before the induction of PAH by MCT administration <ref type="bibr" target="#b1">(2)</ref>.</s><s>The mast-cell stabilizer ketotifen fumarate (Sigma-Aldrich) was administered orally with the drinking water at a dose of 1 mg•kg Ϫ1 •day Ϫ1 starting at day 1 of MCT treatment as previously described <ref type="bibr" target="#b18">(17)</ref>.</s></p><p><s>Hemodynamics and lung histology.</s><s>Hemodynamics and lung vascular remodeling were assessed as previously described <ref type="bibr" target="#b18">(17,</ref><ref type="bibr" target="#b52">50)</ref>.</s><s>In brief, right ventricular systolic pressure (RVSP) was measured by advancing a 1.4-Fr Mikro-Tip catheter (Millar, Houston, TX) through the jugular vein into the right ventricle.</s><s>For histology, lungs were excised, intratracheally instilled with 4% paraformaldehyde (PFA), and fixed for 24 h.</s><s>After dehydration, lungs were paraffin-embedded and cut into 5-m slices.</s><s>For assessment of lung vascular remodeling, lung sections were stained with hematoxylin-eosin, and medial wall thickness was determined as percentage of external vessel diameter; at least 40 vessels per animal were analyzed.</s><s>Mast cells were stained with 0.05% wt/vol toluidine blue for 3 min, and mast-cell numbers were counted in 20 fields and expressed as mast cells per square millimeter.</s><s>Immunofluorescence staining for tryptase as specific marker for mast cells, CD45RA as specific marker for B cells in rats <ref type="bibr" target="#b7">(6)</ref>, CD3 for T cells, and IL-6 was performed using established protocols; primary antibodies were acquired from Abcam (CD3, IL-6, and tryptase; Cambridge, MA) and BioLegend (CD45RA; San Diego, CA), and all secondary antibodies were acquired from BioLegend.</s><s>For autoantibody blots, rat plasma was used as the primary antibody at 1:500 dilution.</s></p><p><s>ELISA and flow cytometry.</s><s>IgG (Abcam) levels in plasma and IL-6 (Thermo Fisher Scientific, Waltham, MA) levels in lung homogenate were determined by ELISA according to the manufacturer's instructions.</s><s>To prepare cells for flow cytometry, bone marrow, lymph node, and spleen tissue were homogenized, and red blood cells were removed using ACK (Ammonium-Chloride-Potassium) Lysing Buffer.</s><s>Lung cells were prepared using a lung tissue dissociation kit (Miltenyi Biotec).</s><s>B cells were stained with a CD45RA antibody, and samples were analyzed using a MACSQuant flow cytometer (Miltenyi Biotec).</s><s>Results were analyzed using MACSQuantify data acquisition and analysis software (Miltenyi Biotec).</s></p><p><s>Gene array analysis.</s><s>Lungs of three control, three aortic banding alone, and three aortic banding and ketotifen-treated rats were removed, and the complete RNA was extracted (Absolutely RNA Miniprep Kit; Stratagene).</s><s>Three micrograms of RNA of each sample were processed according to the One-Cycle Target Labeling protocol (GeneChip Expression Analysis; Affymetrix, Santa Clara, CA).</s><s>Before and after the amplification process, the concentration of RNA was measured by NanoDrop ND-1000 (Thermo Fisher Scientific) analysis.</s><s>The samples were hybridized to the GeneChip Rat Genome 230 2.0 Fig. <ref type="figure">1</ref>.</s><s>Gene array analysis.</s><s>A: volcano plot from whole rat genome microarray analysis (31,000 genes in total); 32 genes are significantly regulated (Ն4-fold change with P Ͻ 0.05) in aortic banding compared with the control group.</s><s>B: volcano plot of these 32 genes, in banded alone compared with banded and ketotifen-treated.</s><s>Marked with an arrow are genes Ͼ2-fold and with P Ͻ 0.05 regulated.</s><s>C: bar graph of the 3 genes (Igj, IgG-2a, and Igha) differentially regulated in control vs. banding and again in banding vs. banding plus ketotifen.</s><s>Igj, immunoglobulin joining chain; IgG-2a, gamma2a immunoglobulin heavy chain; Igha, immunoglobulin heavy chain, alpha.</s><s>Data are means Ϯ SE from n ϭ 3 animals each; *P Ͻ 0.05 vs. control, #P Ͻ 0.05 vs. untreated aortic banding.</s></p><p><s>Array.</s><s>Gene Array data has been deposited at the NCBI's Gene Expression Omnibus under accession number GSE84704.</s></p><p><s>Cell culture.</s><s>To investigate the effect of plasma on pulmonary arterial smooth muscle cell (PASMC) and pulmonary arterial endothelial cell (PAEC) viability and proliferation, the following protocol was applied: 10,000 PASMCs or PAECs were seeded in 96-well plates.</s><s>Before stimulation, cells were kept in quiescent medium (VascuLife basal medium with 1% penicillin-streptomycin and 0% fetal calf serum) overnight.</s><s>Cells were then treated for 24 h with 1:100 diluted plasma from healthy control, MCT, ketotifen-treated MCT, IL-6-depleted MCT, and B cell-depleted MCT rats.</s><s>To assess the effect of the different plasma samples on cell viability, 10 l of alamarBlue reagent (Thermo Fisher Scientific) was added to each 100-l sample followed by a 2-h incubation at 37°C.</s><s>The resulting fluorescence was read on a fluorescence spectrophotometer.</s><s>Experiments were performed in quadruplicate and repeated 7 to 8 times.</s><s>The effect of the different plasma samples on PASMC and PAEC proliferation was determined by [ 3 H]thymidine (Biotrend Chemikalien, Cologne, Germany) incorporation as an index of DNA synthesis, and radioactivity was measured by a scintillation counter (Wallac 1450 MicroBeta TriLux Liquid Scintillation Counter &amp; Luminometer; PerkinElmer, Monza, Italy).</s><s>Experiments were performed in quadruplicate and repeated 5-10 times.</s></p><p><s>Data analysis.</s><s>Data are given as means Ϯ SE.</s><s>Different groups were compared by t-test or ANOVA, followed by Dunnett multiplecomparison test (Prism, version 5.0; GraphPad Software, La Jolla, CA).</s><s>Statistical significance was assumed at P Ͻ 0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p><s>In previous work, our group <ref type="bibr" target="#b9">(8,</ref><ref type="bibr" target="#b18">17)</ref> gave evidence for a crucial role of mast cells in the pathophysiology of PH by demonstrating that mast-cell stabilization by ketotifen or genetic mast-cell deficiency protected rats from lung vascular remodeling in two models of PH, the classic MCT model of PAH and an aortic banding model of pulmonary hypertension secondary to left heart disease.</s><s>To identify mechanisms by which mast cells promote lung vascular remodeling in PH, we performed whole rat genome microarray analyses on rat lung homogenate of sham-operated control rats, rats with established PH following aortic banding, and rats who had undergone aortic banding and were treated with the mast-cell stabilizer ketotifen.</s><s>Out of 31,000 genes analyzed, 32 were differentially regulated (Ն4-fold change with P Ͻ 0.05) in aortic banding rats compared with control animals (Fig. <ref type="figure">1A</ref>).</s><s>Of these 32 genes, only 3 were subsequently regulated by Ͼ2-fold and with P Ͻ 0.05 in ketotifen-treated aortic banding rats vs. aortic banding alone (Fig. <ref type="figure">1B</ref>).</s><s>All 3 genes, Igj, IgG-2a, and Igha, encoded for components of immunoglobulins (Fig. <ref type="figure">1C</ref>), indicating a potential link between mast cells and the adaptive immune response in PH.</s></p><p><s>To consolidate the notion that mast cells may drive immunoglobulin production, we characterized the time course of mast-cell accumulation and IgG production in the aortic banding model of PH and compared it with the temporal profile of lung vascular remodeling and PH development.</s><s>Over the 1st 2 wk, RVSP increased gradually and then plateaued between 40 and 50 mmHg after day 15 (Fig. <ref type="figure" target="#fig_0">2A</ref>), whereas vascular remodeling increased progressively over the entire time course analysis (Fig. <ref type="figure" target="#fig_0">2B</ref>).</s><s>Importantly, histological assessment of mast- cell infiltration showed a rapid surge within the 1st wk, which preceded both hemodynamic and structural changes (Fig. <ref type="figure" target="#fig_0">2C</ref>).</s></p><p><s>In contrast, IgG levels in plasma remained at a low level for the 1st 10 days after which time point they started to increase and had tripled by the end of the 9-wk observation period (Fig. <ref type="figure" target="#fig_0">2D</ref>).</s><s>Taken together, gene array analyses and time profile studies identify mast-cell accumulation as an early event in PH that is critical for the subsequent stimulation of the adaptive immune system.</s><s>To validate the induction of an adaptive immune response in other models of PH, we quantified B-cell levels in circulating blood, lungs, and key organs of the immune system in two experimental models of PAH, namely the MCT and the Sugen/hypoxia model.</s><s>Flow cytometric analysis for CD45RA ϩ cells revealed a relative increase in the abundance of B cells in circulating blood, lymph nodes, and spleen (Fig. <ref type="figure" target="#fig_1">3, A-C</ref>) in both the MCT and the Sugen/hypoxia model.</s><s>The only organ, however, in which the increase in CD45RA ϩ cells reached significance in both models was the lung (Fig. <ref type="figure" target="#fig_1">3, D-F</ref>), substantiating the activation of a local adaptive immune response in different models of PH.</s><s>Of interest, the relative abundance of CD45RA ϩ cells was overall higher in the Sugen/ hypoxia compared with the MCT model, underlining that the observed enrichment in B cells was not attributable to the well-recognized proinflammatory nature of the MCT model <ref type="bibr" target="#b23">(22)</ref>.</s><s>The notable exception among the analyzed tissues was the bone marrow where the abundance of CD45RA ϩ cells was slightly lower in MCT-or Sugen/hypoxia-treated rats compared with controls (Fig. <ref type="figure" target="#fig_1">3G</ref>), consistent with a recruitment of B cells from the bone marrow to extramedullary immunecompetent organs and the lung.</s></p><p><s>We next aimed to identify the mechanistic link that connects mast cells to the adaptive immune system.</s><s>Based on its wellestablished role in both clinical PH and preclinical disease models <ref type="bibr" target="#b14">(13,</ref><ref type="bibr" target="#b19">18,</ref><ref type="bibr" target="#b40">39)</ref> and its documented stimulatory effect on B-cell proliferation and differentiation <ref type="bibr" target="#b26">(25)</ref>, we focused specifically on IL-6.</s><s>Double immunofluorescence staining for mast-cell tryptase and IL-6 in lungs of MCT and Sugen/ hypoxia rats revealed not only that most mast cells (Ͼ85%) also stained for IL-6 but also more importantly that the majority (Ͼ70%) of IL-6-positive cells were tryptase-positive and, hence, mast cells (Fig. <ref type="figure" target="#fig_2">4, A and B</ref>).</s><s>In line with the recognition of mast cells as a major source of IL-6 in PH, IL-6 quantification in lung homogenate by ELISA confirmed increased IL-6 levels in MCT compared with those in control rats, yet IL-6 levels virtually zeroed when MCT rats were treated with the mast-cell stabilizer ketotifen (Fig. <ref type="figure" target="#fig_2">4C</ref>).</s></p><p><s>To corroborate the notion of a critical role for IL-6 in the pathophysiology of PH, we next depleted IL-6 in the MCT model by daily administration of an anti-IL-6 antibody <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b38">37)</ref>.</s><s>Three weeks after MCT, the development of PH and vascular remodeling, assessed as RVSP and medial wall thickness in small-(20 -50 m) and medium-sized (50 -100 m) blood vessels, respectively, were significantly attenuated in IL-6depleted rats compared with untreated MCT rats (Fig. <ref type="figure">5, A-C</ref>).</s><s>Consistent with previously published results <ref type="bibr" target="#b9">(8,</ref><ref type="bibr" target="#b18">17)</ref>, quantification of mast cells by toluidine blue staining revealed an abundance of mast cells in lungs of MCT rats compared with controls.</s><s>Importantly, mast-cell density was not reduced by IL-6 depletion (Fig. <ref type="figure">5D</ref>), indicating that the role of mast cells in PH is not downstream of IL-6.</s><s>To interrogate the role of IL-6 for the adaptive immune response in PH lungs, we next stained lung slides for B cells using a CD45RA antibody as previously described <ref type="bibr" target="#b7">(6)</ref>.</s><s>In all analyzed lung slides, single CD45RA ϩ cells were scant, but CD45RA ϩ cells rather presented in characteristic clusters (Fig. <ref type="figure">5E</ref>) in line with recent reports of tLT in both animal models of PH <ref type="bibr" target="#b7">(6,</ref><ref type="bibr" target="#b32">31)</ref> and clinical samples from patients with PAH <ref type="bibr" target="#b35">(34)</ref>.</s><s>Planimetric quantification revealed a significant increase in tLT size in MCT rats compared with controls, which was attenuated by IL-6 neutralization.</s><s>Notably, CD45RA ϩ cluster size was also found markedly lower in histological samples from a prior study in MCT-treated mast cell-deficient Ws/Ws rats (17), whereas control Ws/Ws rats did not differ from wild-type controls (Fig. <ref type="figure">5F</ref>).</s><s>In addition to B cells, accumulation of T cells presents a characteristic feature of PH that has been implicated in the disease process <ref type="bibr" target="#b33">(32)</ref>.</s><s>In line with this notion, we found the number of CD3 ϩ T cells in tLT to be markedly increased in lungs of MCT-treated compared with control rats.</s><s>Notably, T-cell numbers were significantly decreased in sections from IL-6-depleted rats and showed a trend toward reduced numbers in mast cell-deficient MCT-treated rats, suggesting a critical role for both mast cells and IL-6 in the infiltration of B cells and T cells and the formation and expansion of tLT in experimental PH (Fig. <ref type="figure">5G</ref>).</s></p><p><s>Based on the identification of tLT abundant in CD45RA ϩ B cells, we next probed for the functional role of B cells in lung vascular remodeling and PH using two complementary approaches; a genetic strategy using B cell-deficient JH-KO rats and a pharmacological approach based on depletion of B cells by an anti-CD20 antibody <ref type="bibr" target="#b27">(26)</ref>.</s><s>Both strategies markedly attenuated the development of PH and lung vascular remodeling in the MCT model, as demonstrated by lower RVSP values and reduced medial wall thickness in both small-and mediumsized pulmonary vessels.</s><s>PH and lung vascular remodeling were similarly reduced by B-cell deficiency or depletion, respectively, in a second experimental model of PH, the Sugen/ hypoxia model (Fig. <ref type="figure" target="#fig_3">6</ref>).</s></p><p><s>Based on these data, a novel immunological axis between mast cells and B cells unfolds that is mediated via IL-6 and plays a critical role in PH and lung vascular remodeling.</s><s>To probe for the relevance of this axis for the development of autoimmunity in PH, we assessed rat plasma for the presence of autoantibodies.</s><s>To this end, lung slides of healthy Sprague-Dawley rats were incubated with plasma from control or MCT-treated rats; autoreactive antibodies were subsequently labeled by a fluorescent secondary antibody as previously Fig. <ref type="figure">5</ref>. Functional assessment of IL-6 and quantification of mast cells and B cells in PH.</s><s>Right ventricular systolic pressure (RVSP; A) and medial wall thickness in percentage in small (B)-and medium (C)-sized vessels were determined in healthy control, MCT alone, and IL-6-depleted MCT-treated rats; n ϭ 6 experiments, respectively; *P Ͻ 0.05 vs. control, #P Ͻ 0.05 vs. MCT.</s><s>D: after toluidine blue staining, mast cells were quantified in lung slides of control, MCT, and IL-6-depleted MCT rats, and the result is expressed as mast-cell number per square millimeter; n ϭ 6 experiments, respectively; *P Ͻ 0.05 vs. control; each bar represents mean Ϯ SE.</s><s>E: B cells were stained by an anti-CD45RA antibody, in lung slides of healthy control and MCT-treated rats, representative slides; scale bar ϭ 100 m.</s><s>F: after CD45RA staining, bronchus-associated lymphoid tissue area size in square micrometers was measured in lung slides of control, MCT alone, IL-6-depleted MCT, mast cell-deficient Ws/Ws, and Ws/Ws MCT-treated rats; n ϭ 5-9 experiments, respectively; *P Ͻ 0.05 vs. control; each bar represents mean Ϯ SE.</s><s>G: lung slides of healthy control rats, MCT alone, IL-6-depleted MCT, mast cell-deficient Ws/Ws, and Ws/Ws MCT-treated rats were stained for T cells with an anti-CD3 antibody, and CD3 ϩ cells were expressed per square millimeter of tLT.</s><s>n ϭ 3-4 Experiments, respectively; *P Ͻ 0.05 vs. control, #P Ͻ 0.05 vs. MCT; each bar represents mean Ϯ SE. described <ref type="bibr" target="#b7">(6)</ref>.</s><s>In line with previous reports (6), fluorescence intensity, and therefore the abundance of autoantibodies in plasma, was significantly increased in MCT compared with control rats (Fig. <ref type="figure" target="#fig_4">7A</ref>).</s><s>The resulting fluorescence staining was rather diffuse, indicating the presence of multiple autoantibodies.</s><s>Importantly, autoreactivity was significantly diminished in plasma from MCT rats that had received the mast-cell stabilizer ketotifen, highlighting the role of mast cells for the development of autoimmunity (Fig. <ref type="figure" target="#fig_4">7B</ref>).</s><s>Consistently, IgG levels measured in plasma by ELISA showed a marked tendency (P ϭ 0.079) to increase in MCT relative to control rats, an effect that was again blocked by ketotifen (Fig. <ref type="figure" target="#fig_4">7C</ref>).</s></p><p><s>To address the potential role of autoimmunity in PH further, we incubated PAECs and PASMCs with plasma from healthy control, MCT, ketotifen-treated MCT, IL-6-depleted MCT, and B cell-depleted MCT rats and determined its effect on cell survival and proliferation (Fig. <ref type="figure" target="#fig_4">7, D and E</ref>).</s><s>PAECs and PASMCs that were incubated with plasma from MCT-treated rats alone showed an increase in both cell survival and proliferation in line with progressive pulmonary arterial remodeling of both the intimal and medial layer.</s><s>In PAECs, this effect was by trend less pronounced when cells were incubated with plasma from MCT rats treated with either ketotifen or anti-IL-6 or anti-CD20 antibodies, with a significant attenuation of PAEC proliferation in the case of plasma from IL-6-or B cell-depleted rats.</s><s>In PASMCs, on the other hand, immunotargeted interventions showed virtually no effect on cell proliferation and survival, indicating that SMC proliferation is likely caused by factors independent of the immune response.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Here, we provide evidence for a novel mast cell-B cell axis, driven by the cytokine IL-6, in vascular remodeling and PH.</s><s>Gene array analysis identified components of immunoglobulins as the most prominently regulated mast cell-dependent genes in a model of PH secondary to left heart disease.</s><s>Mast cells were identified as the predominant source of IL-6 in the rat MCT and Sugen/hypoxia model of PH, and IL-6 played an essential role in lung vascular remodeling and PH, as IL-6 depletion by a neutralizing antibody attenuated both effects in the rat MCT model.</s><s>Mast cells and IL-6 were found to drive the formation of tLT abundant in CD45RA ϩ B cells, and B cells were in turn critical for the development of PH and lung vascular remodeling as demonstrated by both pharmacological depletion and genetic deletion.</s><s>Finally, PH was associated with an increased abundance of circulating autoantibodies that could be blocked by mast cell-targeted interventions, yielding a potential mechanistic explanation for the pathogenic role of the identified mast cell-B cell axis in PH.</s></p><p><s>Specific subforms of PH, such as PH associated with systemic sclerosis, mixed connective tissue disease, or systemic lupus erythematosus, have traditionally been linked to inflammatory processes <ref type="bibr" target="#b17">(16,</ref><ref type="bibr" target="#b37">36)</ref>.</s><s>However, in a recent paradigm shift,</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>L717</head><p><s>a critical inflammatory component is increasingly becoming recognized as an important trigger and/or propagator of the disease process in other subforms of PH, which have not been classically linked to autoimmunity or infection.</s><s>Specifically, a critical role for mast cells has been demonstrated in a series of experimental models of PH <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b9">8,</ref><ref type="bibr" target="#b18">17,</ref><ref type="bibr" target="#b21">20)</ref>.</s><s>In previous work from our own laboratory, we could show that treatment with the mast-cell stabilizer ketotifen significantly improves vascular remodeling and PH in rats in both the aortic banding model of PH associated with left heart disease and the MCT model of PAH <ref type="bibr" target="#b18">(17)</ref>.</s><s>Subsequently, the beneficial effects of mast celltargeted interventions could be confirmed in a first clinical pilot study <ref type="bibr" target="#b10">(9)</ref>.</s><s>However, the mechanisms by which mast cells regulate PH are so far unknown.</s><s>Mast cells secrete a range of biologically active mediators, including histamine, serotonin, and mast-cell chymase <ref type="bibr" target="#b12">(11,</ref><ref type="bibr" target="#b45">43)</ref>, all having the potential to contribute critically to the disease process in PH.</s><s>Unexpectedly, our gene array analyses revealed several components of immunoglobulins as the most prominently regulated mast celldependent genes, indicating a functional mast cell-B cell interaction in PH by which mast cells might contribute to the development of PH through mechanisms independent of its classic biogenic amine mediators or enzyme release.</s><s>Although this interplay between the innate and adaptive immune system is a novel concept in PH, mast cells have previously been reported to regulate adaptive immune responses in the context of autoimmunity <ref type="bibr" target="#b12">(11)</ref>.</s><s>Specifically, mast cells may activate B cells and promote their survival, proliferation, and differentiation into antibody-secreting plasma cells <ref type="bibr" target="#b13">(12,</ref><ref type="bibr" target="#b26">25,</ref><ref type="bibr" target="#b46">44)</ref>.</s><s>In line with this notion, time course analyses in rats with aortic banding revealed an increase in circulating IgG that occurred secondary to the infiltration of mast cells into the lungs.</s><s>In two independent models of PAH, flow cytometric analysis detected increased levels of B cells in the lung consistent with previous reports of B-cell infiltration in iPAH patients <ref type="bibr" target="#b32">(31,</ref><ref type="bibr" target="#b47">45)</ref> and secondary forms of PH <ref type="bibr" target="#b8">(7,</ref><ref type="bibr" target="#b50">48)</ref>.</s></p><p><s>IL-6 represents an attractive candidate mediator linking mast cells and B cells in PH, considering that 1) mast cells synthesize and secrete IL-6 <ref type="bibr" target="#b36">(35,</ref><ref type="bibr" target="#b45">43)</ref>, 2) IL-6 promotes B-cell growth and differentiation to plasma cells <ref type="bibr" target="#b46">(44)</ref>, 3) IL-6 stimulates immunoglobulin secretion and autoantibody production by B cells (15), 4) IL-6 levels are strong prognostic predictors of outcome in clinical PAH <ref type="bibr" target="#b19">(18,</ref><ref type="bibr" target="#b39">38)</ref>, and 5) IL-6 overexpression promotes vascular remodeling in experimental PH in mice <ref type="bibr" target="#b40">(39)</ref>.</s><s>In lungs of MCT and Sugen/hypoxia rats, colocalization of mast-cell tryptase and IL-6 identified mast cells as an important source of IL-6 in PH.</s><s>Consistently, IL-6 levels virtually zeroed in MCT rats when animals were treated with the mast-cell stabilizer ketotifen.</s><s>Subsequent studies confirmed the functional relevance of IL-6 in PH, in that IL-6 depletion improved both hemodynamics and vascular remodeling in experimental PH.</s><s>Immunohistological analysis of B-cell infiltration into the lung revealed that B cells organized in characteristic clusters reminiscent of tLT recently described by Perros and colleagues <ref type="bibr" target="#b32">(31)</ref> in lungs of PAH patients.</s><s>The size of these tLTs was significantly increased in experimental PH, yet this effect was attenuated in IL-6-depleted animals, substantiating the notion of a B cell-stimulating effect of IL-6 in PH.</s><s>Of relevance, recent findings by Park and colleagues <ref type="bibr" target="#b31">(30)</ref> indicate that B cells may conversely also have modulating effects on IL-6 levels in PH in that IL-6 levels were reduced almost to control values in B cell-deficient compared with control mice in an allergic model of PH, suggesting a complex interdependence between the innate and the adaptive immune response with interchangeable hierarchies in PH.</s><s>In the present study, we also detected a reduction in tLT in lungs of mast celldeficient rats, giving further support for a functional mast cell-B cell axis in PH.</s><s>Notably, induction of PH by MCT also increased the abundance of T cells in an IL-6-and, putatively, also mast cell-dependent manner.</s><s>This finding indicates a broader role for IL-6-mediated cross talk between the innate and adaptive immune system in PH that is not limited to mast cell-B cell signaling but also regulates T-cell trafficking; a notion that deserves further exploration in future studies in view of the emerging role of T cells in lung vascular remodeling and PH <ref type="bibr" target="#b43">(41,</ref><ref type="bibr" target="#b48">46)</ref>.</s></p><p><s>To establish a functional role for B cells in PH, both a genetic and a pharmacological approach were applied.</s><s>For the genetic approach, we used JH-KO rats in which the JH locus has been deleted by zinc finger nucleases.</s><s>Since the JH locus is required for immunoglobulin expression and immunoglobulins in turn are required for B-cell maturation, JH-KO rats are virtually deficient of mature B cells <ref type="bibr" target="#b25">(24)</ref>.</s><s>Besides the depletion of B cells, JH-KO rats also show other alterations in the</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>L718</head><p><s>MAST CELLS AND B CELLS IN PULMONARY HYPERTENSION composition of their immune system, such as an increased proportion of splenic CD4 ϩ -T cell receptor-positive and CD8 ϩ T-cell receptor-positive cells.</s><s>In a second approach, we therefore depleted B cells by an anti-CD20 antibody using a previously established dosing regimen <ref type="bibr" target="#b41">(40)</ref>.</s><s>Notably, both strategies significantly improved hemodynamics and vascular remodeling in both the MCT and the Sugen/hypoxia model, respectively.</s><s>Depletion of B cells had previously been shown to attenuate experimental PH in a model of combined SU 5416 and ovalbumin challenge by Mizuno and colleagues <ref type="bibr" target="#b27">(26)</ref>.</s><s>Whereas a contribution of B cells may be conceivable in a model of allergic sensitization, our present study extends these findings and suggests a more general role for B cells in PH.</s></p><p><s>The view of B cells playing an active role in the disease process in PH is further supported by genomic analyses, which identified a distinct RNA expression profile in peripheral blood B-lymphocytes indicative of B-cell activation in patients with idiopathic PAH compared with healthy controls <ref type="bibr" target="#b49">(47)</ref>.</s><s>Mechanistically, several studies are currently pointing to a paramount role of reactive autoantibodies in PH <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b7">6,</ref><ref type="bibr" target="#b28">27)</ref>.</s><s>In MCTinduced PH, Colvin and colleagues (6) detected circulating autoantibodies that when utilized as primary antibodies in immunofluorescence staining of normal lung sections showed strong reactivity against epitopes in the adventitia and in small blood vessels.</s><s>In the present study, similar analyses revealed a more uniform pattern of autoreactivity.</s><s>That notwithstanding, fluorescence intensity was significantly increased in lung slides incubated with plasma from MCT animals compared with healthy controls, indicating a general abundance of autoantibodies in circulating blood of MCT rats.</s><s>In line with these results, plasma levels of circulating IgG showed a trend to increase in MCT animals compared with controls, and IgG levels tripled over a 9-wk time course in the aortic banding model of PH.</s><s>It should be noted that the magnitude of this increase is relatively small compared with classic models of immune sensitization and antigen challenge <ref type="bibr" target="#b30">(29)</ref>.</s><s>That notwithstanding, it is likely functionally relevant, as a similar 1.5-to 3-fold increase in IgG levels in the MCT model had previously been described by Colvin and colleagues <ref type="bibr" target="#b7">(6)</ref>, who could show that these IgGs when purified from plasma and transfused sufficed to induce PH in naïve rats.</s><s>Comparable increases in serum IgGs have also been reported in patients with autoimmune diseases, such as systemic lupus erythematosus, Sjögren's syndrome, or systemic sclerosis, which are all commonly associated with the development of PH <ref type="bibr" target="#b22">(21,</ref><ref type="bibr" target="#b53">51)</ref>.</s><s>The notion of increased autoimmunity in PH is furthermore in line with the fact that B cells organized as tLTs in PH lungs, a pattern that is characteristic for autoimmune diseases <ref type="bibr" target="#b34">(33)</ref> and has previously been proposed as a likely source of reactive autoantibodies in PH <ref type="bibr" target="#b7">(6)</ref>.</s><s>Attenuation of both staining of naïve lung slices by autoreactive antibodies and circulating levels of IgG in MCT rats when treated with the mast-cell stabilizer ketotifen identifies the development of autoimmunity as a downstream effector of mast cells.</s><s>In line with the previously proposed concept of antiendothelial autoantibodies in PH <ref type="bibr" target="#b29">(28)</ref>, subsequent cell culture experiments demonstrated an inhibitory effect of immunotargeted interventions on cell proliferation and viability in PAECs yet not in PASMCs.</s></p><p><s>Although the infiltration of inflammatory cells in lungs of patients with PH has been reported for several decades, the pathophysiological relevance of the immune system as a critical driver of lung vascular remodeling is only recently emerging.</s><s>Here, we provide evidence for a novel link between the innate and the adaptive immune system in PH disease in that mast cells, by signaling through IL-6, recruit and/or activate B cells, promoting the formation of tLT as potential germinal centers of autoimmunity and the production or autoreactive antibodies (Fig. <ref type="figure" target="#fig_5">8</ref>).</s><s>Although the exact targets of autoreactive antibodies and the mechanisms by which they trigger or propagate vascular remodeling remain to be elucidated, our findings identify a potentially promising role for targeted immunotherapy in the treatment of PH.</s><s>At present, clinical studies investigating the efficacy of rituximab, an anti-CD20 antibody, for the treatment of systemic sclerosis-associated PH (NCT01086540), or tocilizumab, an IL-6-neutralizing agent, in PAH patients (NCT02676947), are underway.</s><s>Hence, although our understanding of the exact interplay between different immune-cell populations and their downstream effects and targets remains a field of exciting research, the growing recognition of the pivotal role of the immune system in PH may open new therapeutic avenues for improved clinical management of PH patients.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Time course analysis.</s><s>The development of right ventricular systolic pressure (RVSP; A), vascular remodeling (B), pulmonary mast-cell infiltration (C), and plasma IgG levels (D) were recorded at 10 different time points during the 9-wk aortic banding model.</s><s>Each dot represents mean Ϯ SE of n ϭ 6 -8 experiments.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Systemic and local B-cell accumulation in PH.</s><s>B-cell accumulation in the monocrotaline (MCT) and Sugen/hypoxia (Su/Hyp) model of PH, evident by infiltration of CD45RA ϩ cells, were compared with the healthy control (Contr), measured in blood (A), lymph node (LN; B), and spleen (C).</s><s>Representative dot plots from control (D) and Su/Hyp-treated rats (E) are shown.</s><s>B-cell accumulation was measured in lung (F) and bone marrow (BM; G).</s><s>Each bar represents mean Ϯ SE of n ϭ 3-6 experiments, respectively; **P Ͻ 0.05 vs. control, ***P Ͻ 0.05 vs. control.</s><s>PE-A and FITC-A are the fluorescence intensities in the R-phycoerythrin channel and FITC channel, respectively.</s></p></div></figDesc><graphic coords="4,55.46,309.50,491.23,381.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Mast cell-IL-6 costaining.</s><s>Lung slides of monocrotaline (MCT)-and Sugen/hypoxia (Su/Hyp)-treated rats were stained for mast cells by a primary antitryptase antibody and for IL-6 with a primary anti-IL-6 antibody.</s><s>In A, representative slides of MCT-treated rats are shown.</s><s>Scale bar: 30 m. B: quantification of tryptase-positive cells costained with IL-6 (MCs pos for IL6) and IL-6-positive cells costained with tryptase in percent are given for MCT (left)and Su/Hyp (right)-treated rats, respectively.</s><s>C: IL-6 ELISA measurements of lung homogenate of control, MCT alone, and MCT plus ketotifen-treated rats in picograms per milliliter.</s><s>Each bar represents mean Ϯ SE of n ϭ 4 -6 experiments, respectively; #P Ͻ 0.05 vs. MCT alone.</s></p></div></figDesc><graphic coords="5,87.53,263.50,427.23,427.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>Functional assessment of B cells in experimental models of PH.</s><s>Right ventricular systolic pressure (RVSP) and medial wall thickness in percentage in small-and medium-sized vessels were determined in healthy control, MCT in wild-type, and MCT in B cell-deficient JH-KO rats (A-C); in healthy control, MCT-treated with an isotype-matched control antibody, and MCT anti-CD20-treated rats (D-F); in healthy control, Su/Hyp in wild-type, and Su/Hyp in B cell-deficient JH-KO rats (G-I); and in healthy control, Su/Hyp rats treated with an isotype-matched control antibody, and Su/Hyp rats treated with an anti-CD20 antibody (J-L).</s><s>Each bar represents mean Ϯ SE of n ϭ 6 -10 experiments, respectively; *P Ͻ 0.05 vs. control, #P Ͻ 0.05 vs. MCT or Su/Hyp alone, respectively.</s></p></div></figDesc><graphic coords="7,43.50,72.05,515.01,475.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 7 .</head><label>7</label><figDesc><div><p><s>Fig. 7. Autoantibodies in PH.</s><s>A: the presence of autoantibodies was examined in plasma of control, MCT alone, and MCT plus ketotifen-treated rats, representative slides.</s><s>Scale Bar ϭ 30 m. B: fluorescence intensity was measured in lung slides incubated with plasma of control, MCT alone, and MCT plus ketotifen-treated rats.</s><s>C: IgG ELISA measurements in nanograms per milliliter in control, MCT alone, and MCT plus ketotifen-treated rats.</s><s>Pulmonary arterial smooth muscle cells (PASMC; D) and pulmonary arterial endothelial cells (PAEC; E) were treated with plasma from healthy control, MCT alone, ketotifen-treated MCT, IL-6-depleted MCT, and B cell-depleted MCT rats, and cell proliferation and viability were measured relative to control (CTL).</s><s>Each bar represents mean Ϯ SE of n ϭ 4 experiments, respectively; *P Ͻ 0.05 vs. control, #P Ͻ 0.05 vs. MCT.</s></p></div></figDesc><graphic coords="8,56.46,71.92,489.00,417.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 8 .</head><label>8</label><figDesc><div><p><s>Fig.8.</s><s>Proposed concept for a mast cell-B cell axis and a critical role for B cells in pulmonary hypertension.</s><s>The scheme depicts the proposed sequence of events by which mast cells and B cells are expected to promote the development of pulmonary hypertension and lung vascular remodeling.</s><s>At an early stage during the onset of pulmonary hypertension, mast cells accumulate in the lung perivascular space and release their abundance of stored mediators and enzymes by degranulation.</s><s>Of the soluble mediators released, we propose interleukin-6 (IL-6) to play a prominent role in the recruitment, activation, and differentiation of B cells in pulmonary hypertension.</s><s>B cells then promote endothelial dysfunction and apoptosis, resulting in vascular remodeling and, ultimately, pulmonary hypertension.</s><s>The critical role of B cells in pulmonary hypertension may be attributable to an autoantibody-mediated response.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="2,331.28,221.50,204.22,415.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0"><head></head><label></label><figDesc><div><p></p></div></figDesc><graphic coords="6,43.50,71.82,516.00,369.00" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">AJP-Lung Cell Mol Physiol• doi:10.1152/ajplung.00311.2016 • www.ajplung.org Downloaded from journals.physiology.org/journal/ajplung (176.172.000.127) on May 17, 2022.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>We thank Genentech for providing us with the anti-CD20 and isotypematched control antibody.</s><s>Furthermore, we thank Chris Spring, Dr. Caterina Di Ciano-Oliveira, and Xiaofeng Lu from the Keenan Research Centre Core Facility as well as the St. Michael's Vivarium staff for technical support and Neha Sharma, from the Medical University of Graz, Austria, for assistance with the cell culture experiments.</s><s>Last but not least, we thank Dr. Pingzhao Hu, Assistant Professor at the Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Canada, for help with Bioconductor.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GRANTS</head><p><s>This study was supported by a Heart and Stroke Foundation of Canada grant to W. M. Kuebler.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCLOSURES</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Arends</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Damoiseaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Duijvestijn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Debrus-Palmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Boomars</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Broers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cohen</forename><surname>Tervaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Van Paassen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00164209</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="923" to="925" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Aricha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mizrachi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fuchs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Souroujon</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jaut.2010.12.001</idno>
	</analytic>
	<monogr>
		<title level="j">J Autoimmun</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Mast cell inhibition improves pulmonary vascular remodeling in pulmonary hypertension</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bartelds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Van Loon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mohaupt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wijnberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Boersma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Takens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Van Albada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Berger</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.11-0663</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="651" to="660" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kutsche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Guenther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tabeling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Witzenrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Kühl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Heidecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Ghofrani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tiede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Schermuly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nickel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hoeper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Lukitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gollasch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">R</forename><surname>Burmester</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dragun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Riemekasten</surname></persName>
		</author>
		<title level="m">Vascular receptor autoantibodies in pulmonary arterial hypertension associated with L719</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<author>
			<persName><surname>Mast</surname></persName>
		</author>
		<author>
			<persName><surname>In</surname></persName>
		</author>
		<author>
			<persName><surname>Hypertension</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">• www.ajplung.org Downloaded from journals.physiology.org/journal/ajplung (176.172.000.127) on May 17, 2022. systemic sclerosis</title>
		<idno type="DOI">10.1164/rccm.201403-0442OC</idno>
		<idno>doi:10.1164/rccm.201403-0442OC</idno>
	</analytic>
	<monogr>
		<title level="j">AJP-Lung Cell Mol Physiol</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="808" to="817" />
			<date type="published" when="2014">2016. 2014</date>
		</imprint>
	</monogr>
	<note>Am J Respir Crit Care Med</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The pathophysiology of pulmonary hypertension in left heart disease</title>
		<author>
			<persName><forename type="first">S</forename><surname>Breitling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ravindran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Goldenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajplung.00146.2015</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Lung Cell Mol Physiol</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="L924" to="L941" />
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Bronchusassociated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Colvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Cripe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Ivy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Stenmark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Yeager</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201302-0403OC</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="page" from="1126" to="1136" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Cool</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kennedy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Voelkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Tuder</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0046-8177%2897%2990032-0</idno>
	</analytic>
	<monogr>
		<title level="j">Hum Pathol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="434" to="442" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Dahal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kosanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kaulen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Cornitescu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Savai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Ghofrani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Weissmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Seeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Grimminger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Schermuly</surname></persName>
		</author>
		<idno type="DOI">10.1186/1465-9921-12-60</idno>
	</analytic>
	<monogr>
		<title level="j">Respir Res</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page">60</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Mast cell number, phenotype, and function in human pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">S</forename><surname>Farha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sharp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Asosingh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Comhair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Farver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Loyd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Erzurum</surname></persName>
		</author>
		<idno type="DOI">10.4103/2045-8932.97609</idno>
	</analytic>
	<monogr>
		<title level="j">Pulm Circ</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="220" to="228" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The pharmacological treatment of pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">R</forename><surname>Frumkin</surname></persName>
		</author>
		<idno type="DOI">10.1124/pr.111.005587</idno>
	</analytic>
	<monogr>
		<title level="j">Pharmacol Rev</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="583" to="620" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Mast cells in the development of adaptive immune responses</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Galli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nakae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tsai</surname></persName>
		</author>
		<idno type="DOI">10.1038/ni1158</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="135" to="142" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Induction of human IgE synthesis in B cells by mast cells and basophils</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Gauchat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Henchoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mazzei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Aubry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Brunner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Blasey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Life</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Talabot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Flores-Romo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Butterfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dahinden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Bonnefoy</surname></persName>
		</author>
		<idno type="DOI">10.1038/365340a0</idno>
		<idno>doi:10. 1038/365340a0</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">365</biblScope>
			<biblScope unit="page" from="340" to="343" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Inflammatory cytokines in pulmonary hypertension</title>
		<author>
			<persName><forename type="first">A</forename><surname>Groth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Vrugt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Speich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ulrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Huber</surname></persName>
		</author>
		<idno type="DOI">10.1186/1465-9921-15-47</idno>
	</analytic>
	<monogr>
		<title level="j">Respir Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">47</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Inhalation of the phosphodiesterase-3 inhibitor milrinone attenuates pulmonary hypertension in a rat model of congestive heart failure</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hentschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Riad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Habbazettl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Weimann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Koster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschope</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
		</author>
		<idno type="DOI">10.1097/00000542-200701000-00021</idno>
		<idno>doi:10. 1097/00000542-200701000-00021</idno>
	</analytic>
	<monogr>
		<title level="j">Anesthesiology</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="124" to="131" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Interleukin-6 and its relation to inflammation and disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hirano</surname></persName>
		</author>
		<idno type="DOI">10.1016/0090-1229%2892%2990042-M</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Immunol Immunopathol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="S60" to="S65" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Pulmonary hypertension in collagen vascular disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Hoeper</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.02.01512001</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="571" to="576" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Mast cells promote lung vascular remodelling in pulmonary hypertension</title>
		<author>
			<persName><forename type="first">J</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kukucka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Saarikko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sterner-Kock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fujii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Leong-Poi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Schermuly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.00043310</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="1400" to="1410" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension</title>
		<author>
			<persName><forename type="first">M</forename><surname>Humbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Monti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Brenot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sitbon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Portier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grangeot-Keros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Duroux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Galanaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Simonneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Emilie</forename><forename type="middle">D</forename></persName>
		</author>
		<idno type="DOI">10.1164/ajrccm.151.5.7735624</idno>
		<idno>doi:10. 1164/ajrccm.151.5.7735624</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">151</biblScope>
			<biblScope unit="page" from="1628" to="1631" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">N</forename><surname>Kherbeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Tamby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bussone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dib</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Perros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Humbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mouthon</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12016-011-8265-z</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Rev Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="31" to="38" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Histological characterization of mast cell chymase in patients with pulmonary hypertension and chronic obstructive pulmonary disease</title>
		<author>
			<persName><forename type="first">D</forename><surname>Kosanovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Dahal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Peters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seimetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wygrecka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Antel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Reiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Ghofrani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Weissmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Grimminger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Seeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Schermuly</surname></persName>
		</author>
		<idno type="DOI">10.1086/675642</idno>
	</analytic>
	<monogr>
		<title level="j">Pulm Circ</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="128" to="136" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">IgG subclass serum levels in systemic lupus erythematosus patients</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10067-009-1224-x</idno>
	</analytic>
	<monogr>
		<title level="j">Clin Rheumatol</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1315" to="1318" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?</title>
		<author>
			<persName><forename type="first">G</forename><surname>Maarman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lecour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Butrous</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Thienemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Sliwa</surname></persName>
		</author>
		<idno type="DOI">10.1086/674770</idno>
	</analytic>
	<monogr>
		<title level="j">Pulm Circ</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="739" to="756" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">V</forename><surname>Mclaughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Presberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Doyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Abman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Mccrory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fortin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ahearn</surname></persName>
		</author>
		<idno type="DOI">10.1378/chest.126.1_suppl.78S</idno>
	</analytic>
	<monogr>
		<title level="j">Chest</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="page" from="78S" to="92S" />
			<date type="published" when="2004">2004</date>
			<publisher>American College of Chest Physicians</publisher>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Characterization of immunoglobulin heavy chain knockout rats</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ménoret</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Iscache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Tesson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rémy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Usal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Osborn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Cost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Brüggemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Buelow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Anegon</surname></persName>
		</author>
		<idno type="DOI">10.1002/eji.201040939</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Immunol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="2932" to="2941" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Merluzzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Frossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Parusso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tripodo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pucillo</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2009-10-250126</idno>
		<idno>doi:10. 1182/blood-2009-10-250126</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="2810" to="2817" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mizuno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Farkas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Al</forename><surname>Husseini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farkas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gomez-Arroyo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kraskauskas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Nicolls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Cool</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bogaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Voelkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename></persName>
		</author>
		<idno type="DOI">10.1165/rcmb.2012-0077OC</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Cell Mol Biol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="679" to="687" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Fine specificity of anti-fibrillin-1 autoantibodies in primary pulmonary hypertension syndrome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Morse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Antohi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kasturi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fotino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Humbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Simonneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Basst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Bona</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1365-3083.2000.00733.x</idno>
	</analytic>
	<monogr>
		<title level="j">Scand J Immunol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="607" to="611" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Autoimmunity and pulmonary hypertension: a perspective</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Nicolls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Taraseviciene-Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Rai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Badesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Voelkel</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.05.00045705</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1110" to="1118" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">IL-13 regulates the immune response to inhaled antigens</title>
		<author>
			<persName><forename type="first">J</forename><surname>Padilla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Daley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Parthasarathi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Mckenzie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tschernig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Kurup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Donaldson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grunig</surname></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.174.12.8097</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope unit="page" from="8097" to="8105" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">The effects of antigen-specific IgG1 antibody for the pulmonary-hypertension-phenotype and B cells for inflammation in mice exposed to antigen and fine particles from air pollution</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Durmus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bleck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reibman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Riemekasten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grunig</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0129910</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">F</forename><surname>Perros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dorfmüller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Montani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Hammad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Waelput</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Girerd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Mercier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mussot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cohen-Kaminsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Humbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Lambrecht</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201105-0927OC</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="page" from="311" to="321" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">M</forename><surname>Rabinovitch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Guignabert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Humbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Nicolls</surname></persName>
		</author>
		<idno type="DOI">10.1161/CIRCRESAHA.113.301141</idno>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="165" to="175" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Bronchus-associated lymphoid tissue (BALT) structure and function</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Randall</surname></persName>
		</author>
		<idno type="DOI">10.1016/B978-0-12-381300-8.00007-1</idno>
	</analytic>
	<monogr>
		<title level="j">Adv Immunol</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="187" to="241" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">R</forename><surname>Savai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Pullamsetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kolbe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bieniek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Voswinckel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scheed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ritter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Dahal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Vater</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Klussmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Ghofrani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Weissmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Klepetko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Banat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Seeger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Grimminger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Schermuly</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.201202-0335OC</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">186</biblScope>
			<biblScope unit="page" from="897" to="908" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">The master switch: the role of mast cells in autoimmunity and tolerance</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Sayed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Christy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Quirion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Brown</surname></persName>
		</author>
		<idno type="DOI">10.1146/annurev.immunol.26.021607.090320</idno>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="705" to="739" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Updated clinical classification of pulmonary hypertension</title>
		<author>
			<persName><forename type="first">G</forename><surname>Simonneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">M</forename><surname>Robbins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beghetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Channick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Delcroix</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Denton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Elliott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Gaine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Gladwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">C</forename><surname>Jing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Krowka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Langleben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Nakanishi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Souza</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jacc.2009.04.012</idno>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="S43" to="S54" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Illuminating the interrelated immune and endocrine adaptations after multiple exposures to short immobilization stress by in vivo blocking of IL-6</title>
		<author>
			<persName><forename type="first">C</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Louw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Myburgh</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajpregu.00602.2006</idno>
		<idno>doi:10.1152/ ajpregu.00602</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">292</biblScope>
			<biblScope unit="page" from="R1439" to="R1447" />
			<date type="published" when="2006">2007. 2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">E</forename><surname>Soon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Treacy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Doughty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Southgate</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Machado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Trembath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jennings</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Barker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nicklin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Budd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pepke-Zaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">W</forename><surname>Morrell</surname></persName>
		</author>
		<idno type="DOI">10.1161/CIRCULATIONAHA.109.933762</idno>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="page" from="920" to="927" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Interleukin-6 overexpression induces pulmonary hypertension</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">L</forename><surname>Syrkina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kolliputi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Mark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Hales</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Waxman</surname></persName>
		</author>
		<idno type="DOI">10.1161/CIRCRESAHA.108.182014</idno>
	</analytic>
	<monogr>
		<title level="j">Circ Res</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="236" to="244" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title level="m" type="main">B cell depletion attenuated right ventricular hypertrophy and pulmonary vascular mononuclear infiltrates in an experimental model of pulmonary arterial hyper-L720 MAST CELLS AND B CELLS IN PULMONARY HYPERTENSION</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Sung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Tamosiuniene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Nicolls</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title/>
		<idno>176.172.000.127</idno>
		<ptr target="/ajplung.00311.2016•www.ajplung.orgDownloadedfromjournals.physiology.org/journal/ajplung" />
	</analytic>
	<monogr>
		<title level="j">AJP-Lung Cell Mol Physiol</title>
		<imprint>
			<date type="published" when="2011">2011</date>
			<publisher>American Thoracic Society International Conference Abstracts</publisher>
		</imprint>
	</monogr>
	<note>on May 17, 2022. tension (Abstract</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">CD4ϩ T cells and IFN-␥ are required for the development of Pneumocystis-associated pulmonary hypertension</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Swain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Siemsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Pullen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Han</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajpath.2013.10.027</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="483" to="493" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension</title>
		<author>
			<persName><forename type="first">L</forename><surname>Taraseviciene-Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Scerbavicius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Choe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cool</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Tuder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Burns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kasper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Voelkel</surname></persName>
		</author>
		<idno type="DOI">10.1152/ajplung.00491.2005</idno>
		<idno>doi:10.1152/ ajplung.00491</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Lung Cell Mol Physiol</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="L668" to="L676" />
			<date type="published" when="2005">2006. 2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Differential release of mast cell mediators and the pathogenesis of inflammation</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Theoharides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kempuraj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tagen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Conti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kalogeromitros</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1600-065X.2007.00519.x</idno>
	</analytic>
	<monogr>
		<title level="j">Immunol Rev</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="page" from="65" to="78" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Mouse bone marrow-derived mast cells and mast cell lines constitutively produce B cell growth and differentiation activities</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tkaczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Frandji</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Botros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Poncet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lapeyre</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Peronet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mécheri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="1720" to="1728" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Tuder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Groves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Badesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Voelkel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Pathol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="275" to="285" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Increased regulatory and decreased CD8ϩ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ulrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Nicolls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Taraseviciene</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Speich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Voelkel</surname></persName>
		</author>
		<idno type="DOI">10.1159/000111548</idno>
	</analytic>
	<monogr>
		<title level="j">Respiration</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="272" to="280" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ulrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Taraseviciene-Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Speich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Voelkel</surname></persName>
		</author>
		<idno type="DOI">10.1186/1465-9921-9-20</idno>
	</analytic>
	<monogr>
		<title level="j">Respir Res</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">20</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">F</forename><surname>Voelkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Tuder</surname></persName>
		</author>
		<idno type="DOI">10.1183/09031936.95.08122129</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Respir J</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="2129" to="2138" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Autoimmune aspects of primary pulmonary hypertension</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yanai-Landau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Amital</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Bar-Dayan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Levy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">J</forename><surname>Alosachie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Peter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shoenfeld</surname></persName>
		</author>
		<idno type="DOI">10.1159/000163936</idno>
		<idno>doi:10.1159/ 000163936</idno>
	</analytic>
	<monogr>
		<title level="j">Pathobiology</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="71" to="75" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease</title>
		<author>
			<persName><forename type="first">N</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kaestle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hentschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Pries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuppe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Kuebler</surname></persName>
		</author>
		<idno type="DOI">10.1097/CCM.0b013e3181962ce6</idno>
	</analytic>
	<monogr>
		<title level="j">Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="980" to="986" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Serum IgG subclasses in autoimmune diseases</title>
		<author>
			<persName><forename type="first">H</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Shi</surname></persName>
		</author>
		<idno type="DOI">10.1097/MD.0000000000000387</idno>
	</analytic>
	<monogr>
		<title level="j">Medicine (Baltimore)</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page">e387</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
